Skip to main content

SureMASTR: Rebranding and removal of GeneScan reagents

Agilent Technologies is rebranding the MASTR assays! As of the 2nd of November, you will see that some of your familiar MASTR solutions will be rebranded to a new name: SureMASTR. Furthermore, the drMID kits (For Research Use Only. Not for use in diagnostic procedures) will be reconfigured.

What does this change entail?

On November 2nd, the name of five initial MASTR assays will be changed to SureMASTR. Next to a name change, the Multiplicom boxes will be replaced by Agilent-branded boxes and IFU's aligned with the Agilent lay-out. The key-codes of these products will be adapted. The part numbers and content of these kits will not change. As of November 2nd, it will no longer be possible to order the MASTR branded versions of these five assays. The MASTR assay stock will first be exhausted, so it is possible you will still receive a non-rebranded MASTR product instead of a SureMASTR kit within the first month after the rebranding. Please find enclosed the quality statement confirming that the MASTR and SureMASTR kit have no differences within content.

Not only are the MASTR Assays below being rebranded, but also the drMID for Illumina NGS Systems kits will be reconfigured and rebranded. The key-code, part numbers, boxes and content will change. The GeneScan labeling mix (GS-labeling PCR mix) for Quality Control (fragment length analysis option) will be removed from the drMID kits. There will no longer be any references in the IFU's to ABI Capillary Sequencer with GeneScan module. You will be able to order the non-rebranded until May 1st, 2019. After May 1st, 2019, you will only be able to order the new drMID Kits without GeneScan labeling mix.

What needs to be done?

Please check the list below to see if these changes have an impact and are applicable for you.

For customers using the GeneScan labeling mix for Quality Control, alternatives will be provided in the IFUs. Next to this, Customer Support will provide an application note on how to perform this QC step upon request. Contact the customer support team for any further questions.

Which products will be affected how on November 2nd?

Part Number

Name

New Name

Change

New part number

MR-0320.024

BRCA Hereditary Cancer MASTR Plus

SureMASTR Hereditary Cancer

Name change & new boxes

NA

MR-1320.024

BRCA Hereditary Cancer MASTR Plus + MASTR Reporter

SureMASTR Hereditary Cancer + MASTR Reporter

Name change & new boxes

NA

MR-0200.024

Tumor Hotspot MASTR Plus

SureMASTR Tumor Hotspot

Name change & new boxes

NA

MR-1200.024

Tumor Hotspot MASTR Plus + MASTR Reporter

SureMASTR Tumor Hotspot + MASTR Reporter

Name change & new boxes

NA

MR-0141.024

ADH MASTR v2

SureMASTR ADH

Name change & new boxes

NA

MR-0100.024

MODY MASTR

SureMASTR MODY

Name change & new boxes

NA

MR-0160.024

TP53 MASTR

SureMASTR TP53

Name change & new boxes

NA

ML-0208.240

drMID 1-48 for Illumina NGS Systems

drMID 1-48 for Illumina NGS Systems

Change in kit configuration, new product code & new boxes

ML-0210.240

ML-0209.240

drMID 49-96 for Illumina NGS Systems

drMID 49-96 for Illumina NGS Systems

Change in kit configuration, new product code & new boxes

ML-0211.240

QC-0521.100

QC Plex

QC Plex

New boxes

NA


Agilent will keep you informed and up to date on the rebranding changes.


Please don't hesitate to contact the Customer Service team!
mtp.customerservice@agilent.com